about
Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatmentHigh prevalence of primary multidrug resistant tuberculosis in persons with no known risk factorsRapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisFeasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter StudyClinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru.Association of major depressive episode with negative outcomes of tuberculosis treatmentKnowledge about HIV prevention and transmission among recently diagnosed tuberculosis patients: a cross sectional study.Public transportation and tuberculosis transmission in a high incidence setting.A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.Implementation of a stepped-wedge cluster randomized design in routine public health practice: design and application for a tuberculosis (TB) household contact study in a high burden area of Lima, Peru.Oxacillin-resistant and multidrug-resistant Staphylococcus aureus in Lima, Peru.Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure.Design and use of mouse control DNA for DNA biomarker extraction and PCR detection from urine: Application for transrenal Mycobacterium tuberculosis DNA detection.Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru.Manual MGIT™ system for the detection of Mycobacterium tuberculosis: insights from a high TB burden setting.Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru.Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru.[Resistance to second-line anti-tuberculosis drugs among peruvian multidrug resistant Mycobacterium tuberculosis strains]La prueba rápida MODS: Comentario de los editores
P50
Q28477499-D8E7950C-1C57-4EA1-8725-4476947D1D17Q28477658-EE3981B5-C579-4707-9602-03EC20B89645Q28477855-FE939A3A-89DE-4ECC-AF76-66E5E0FD7390Q28828650-B15391C7-CE7E-401A-9599-6B28A187CD23Q33658873-D1D64873-8CE1-49FA-A778-D54754920563Q34412632-CF5CEBE4-7DAD-485E-A383-B7647A4AF383Q34902852-107050B1-514F-4804-BDC9-805BF8728236Q35077011-BF36D67C-F614-4856-AEA7-F14B44E1F5C1Q35113177-D4199A35-3BD7-4C0F-8E34-35D68DC23962Q35528326-B1AB479D-DA14-40A0-A1B5-92EB9CAFF37BQ35673660-AEC33D3D-0CA7-48D7-8D54-DB84FB3BD6BDQ36390533-0B1B852C-5EBB-44A9-AF87-4A422ECBE020Q37434341-56D8EEB9-31BD-4F05-B9ED-49B7FC8CB00FQ38914967-6A7F526B-6F89-4D48-9784-74169591E06CQ39363118-409CCE9C-4C58-4076-A8E5-50521A905319Q39375524-CBE2206C-C44E-4BF2-B7D8-CFCB2E2DDC10Q39449565-368B8090-1053-4A02-A75E-57B2B888C689Q39449576-6E56EB4A-5228-4F76-BA0B-01FBFBF96F9DQ59328669-78067EB0-C6AE-499B-9968-F35EF3BC45B6Q59328677-9C6E2176-69D5-4DBB-BCEC-0254B610B2FE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlos Zamudio
@ast
Carlos Zamudio
@en
Carlos Zamudio
@es
Carlos Zamudio
@nl
Carlos Zamudio
@sl
type
label
Carlos Zamudio
@ast
Carlos Zamudio
@en
Carlos Zamudio
@es
Carlos Zamudio
@nl
Carlos Zamudio
@sl
prefLabel
Carlos Zamudio
@ast
Carlos Zamudio
@en
Carlos Zamudio
@es
Carlos Zamudio
@nl
Carlos Zamudio
@sl
P106
P21
P31
P496
0000-0001-7479-127X